Hotchkis & Wiley Capital Management Upped Its Glaxosmithkline Plc (GSK) Holding; Office Depot (ODP)’s Sentiment Is 1.31

December 7, 2017 - By Michael Collier

Hotchkis & Wiley Capital Management Llc increased Glaxosmithkline Plc (GSK) stake by 4.29% reported in 2017Q2 SEC filing. Hotchkis & Wiley Capital Management Llc acquired 322,700 shares as Glaxosmithkline Plc (GSK)’s stock rose 5.47%. The Hotchkis & Wiley Capital Management Llc holds 7.85 million shares with $338.38M value, up from 7.52M last quarter. Glaxosmithkline Plc now has $80.81B valuation. The stock decreased 0.57% or $0.2 during the last trading session, reaching $34.66. About 5.77 million shares traded or 18.67% up from the average. GlaxoSmithKline plc (NYSE:GSK) has risen 4.26% since December 7, 2016 and is uptrending. It has underperformed by 12.44% the S&P500.

Office Depot, Inc., together with its subsidiaries, supplies office services and products in North America. The company has market cap of $1.68 billion. The firm operates in two divisions, North American Retail and North American Business Solutions. It has a 4.22 P/E ratio. It offers office supplies, technology products and solutions, business machines and related supplies, facilities products, and office furniture, as well as copy and print services.

Hotchkis & Wiley Capital Management Llc decreased Mdc Partners Inc (NASDAQ:MDCA) stake by 125,560 shares to 2.46M valued at $24.37 million in 2017Q2. It also reduced Honda Motor Ltd (NYSE:HMC) stake by 80,100 shares and now owns 2.77M shares. Rockwell Collins Inc (NYSE:COL) was reduced too.

Among 16 analysts covering GlaxoSmithKline (NYSE:GSK), 7 have Buy rating, 1 Sell and 8 Hold. Therefore 44% are positive. GlaxoSmithKline had 25 analyst reports since September 8, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, July 14 by Jefferies. On Wednesday, December 9 the stock rating was upgraded by Bank of America to “Buy”. On Wednesday, July 5 the stock rating was downgraded by Citigroup to “Neutral”. The firm earned “Buy” rating on Wednesday, January 27 by Bryan Garnier & Cie. The firm has “Hold” rating given on Friday, February 26 by Cantor Fitzgerald. The rating was downgraded by Morgan Stanley to “Underweight” on Friday, September 8. As per Monday, December 7, the company rating was maintained by Argus Research. The firm has “Neutral” rating by JP Morgan given on Monday, October 12. Bank of America upgraded GlaxoSmithKline plc (NYSE:GSK) on Tuesday, September 8 to “Neutral” rating. The firm has “Neutral” rating by BNP Paribas given on Tuesday, September 15.

Ratings analysis reveals 0 of Office Depot’s analysts are positive. Out of 2 Wall Street analysts rating Office Depot, 0 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. ODP was included in 2 notes of analysts from October 28, 2016. Telsey Advisory maintained Office Depot, Inc. (NASDAQ:ODP) rating on Friday, October 28. Telsey Advisory has “Market Perform” rating and $4.5 target. The stock has “Hold” rating by Loop Capital on Tuesday, December 13.

The stock decreased 0.31% or $0.01 during the last trading session, reaching $3.26. About 4.74 million shares traded. Office Depot, Inc. (ODP) has risen 51.05% since December 7, 2016 and is uptrending. It has outperformed by 34.35% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Michael Collier




Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: